Bionomics

Contact
bionomics.com.au
+18312463642

Bionomics Limited

200 Greenhill Road
5063 Eastwood
Australia
+18312463642
bionomics.com.au
Contact
Profile News
Contact

About Bionomics

Bionomics is a leading international biotechnology company which discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule product development programs in the areas of cancer, anxiety, epilepsy and multiple sclerosis.

Read more about Bionomics
Facts about Bionomics
  • Focus : Laboratory
  • Industry : Pharma

News about Bionomics

Bionomics

23-Apr-2015 | research and development

Bionomics initiates Phase II clinical trial of anxiety treatment

Bionomics Limited announced the initiation of a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety ...

Read news
Bionomics

18-Sep-2012 | business & finance

Bionomics Acquires US-Based Cancer Stem Cell Company Eclipse Therapeutics

Acquisition provides Bionomics with cancer stem cell technology and antibody drug candidates

Read news
Bionomics

24-May-2012 | research and development

Bionomics launches ovarian cancer trial

Bionomics Limited has launched a Phase I/II clinical trial of its vascular disrupting agent BNC105 in women with ovarian cancer.  It is anticipated that up ...

Read news
Bionomics

06-Jan-2012 | business & finance

Ironwood Pharmaceuticals and Bionomics announce collaboration research

Companies to Collaborate on Central Nervous System Disorder Opportunity

Read news
Bionomics

04-Aug-2011 | research and development

Bionomics BNC105 cancer clinical trials reach key milestones

Clinical program to be expanded

Read news
Bionomics

31-Mar-2011 | research and development

Bionomics anti-axiety drug Phase Ib clinical trials deliver successful results

BNC210 significantly reduced panic symptoms and faster than placebo

Read news
Bionomics

23-Feb-2011 | research and development

Benitec’s Hepatitis B RNAi Program with Biomics Biotechnologies Moves to the Next Stage Following Successful Stage 1 Results

Benitec Limited announced that following the success of the first stage of its anti-viral program to develop an RNA interference (RNAi)-based therapy ...

Read news
Bionomics

06-Oct-2010 | research and development

European Approval Granted for Two Phase Ib Clinical Trials of Bionomics' BNC210

First trial will evaluate the potential for BNC210 to relieve panic attacks and reduce symptoms of anxiety

Read news
Show more news about Bionomics

Here you will find Bionomics Limited